48
Participants
Start Date
December 18, 2019
Primary Completion Date
May 10, 2024
Study Completion Date
May 10, 2024
Lidocaine
Intervention group (A) will receive P-IVLT in addition to the standard multimodal analgesia. P-IVLT will consist of 1 mg/kg bolus at start of anesthesia (T0), followed by 2 mg·kg-1·hr-1 infusion for 8 hours (T1), then continued at 1 mg·kg-1·hr-1 infusion thereafter and postoperatively until T0 + 48 hours (T2).
Saline Solution
Control group (B) will receive a placebo (0.9% sodium chloride also known as normal saline), made to mimic the intervention protocol described above, in addition to the standard multimodal analgesia.
BC Children's Hospital - Department of Anesthesia, Vancouver
University of British Columbia
OTHER